Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (24)

2024

  1. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study

    Revista Espanola de Cardiologia

2023

  1. Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

    British Journal of Haematology

2022

  1. The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

    Frontiers in Oncology, Vol. 12

2021

  1. Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial

    Blood Advances, Vol. 5, Núm. 3, pp. 760-770

  2. The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the pethema-flugaza phase 3 clinical trial

    Cancers, Vol. 13, Núm. 10

2016

  1. Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under lendex: A longitudinal analysis

    Blood, Vol. 127, Núm. 9, pp. 1151-1162

2008

  1. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: Updated time-to-events results and prognostic factors for time to progression

    Haematologica, Vol. 93, Núm. 4, pp. 560-565

2005

  1. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells

    Cancer Research, Vol. 65, Núm. 8, pp. 3264-3272

2001

  1. Antiapoptotic protein Bcl-xL is up-regulated during megakaryocytic differentiation of CD34+ progenitors but is absent from senescent megakaryocytes

    Experimental Hematology, Vol. 29, Núm. 6, pp. 728-735

  2. Ex vivo expansion of umbilical cord blood (UCB) CD34+ cells alters the expression and function of α4β1 and α5β1 integrins

    British Journal of Haematology, Vol. 115, Núm. 1, pp. 213-221

  3. Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features

    Hematology Journal, Vol. 2, Núm. 4, pp. 234-241

  4. Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantation

    Bone Marrow Transplantation, Vol. 27, Núm. 3, pp. 287-293

  5. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation

    Journal of Clinical Microbiology, Vol. 39, Núm. 11, pp. 3938-3941

2000

  1. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-x(L)

    Journal of Experimental Medicine, Vol. 191, Núm. 6, pp. 977-984

  2. Cell signaling by adhesion receptors in normal and leukemic hematopoiesis

    Hematopoietic Stem Cell Transplantation (CRC Press), pp. 125-136

  3. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome

    Bone Marrow Transplantation, Vol. 25, Núm. 11, pp. 1203-1208

  4. Delayed graft-versus-leukemia effect after allogeneic peripheral stem cell transplantation in a patient with chronic lymphocytic leukemia

    Haematologica, Vol. 85, Núm. 3, pp. 330-332

  5. Electrothermal atomic absorption spectrometric diagnosis of familial hypercholesterolemia

    Analytical Chemistry, Vol. 72, Núm. 11, pp. 2406-2413

1999

  1. Erythropoietin can induce the expression of Bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

    Journal of Biological Chemistry, Vol. 274, Núm. 32, pp. 22165-22169

  2. Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC)

    Bone Marrow Transplantation, Vol. 23, Núm. 11, pp. 1101-1107